- Home
- TITN vs PRTA Comparison
TITN vs PRTA Comparison
Compare TITN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TITN
- PRTA
- Stock Information
- Founded
- TITN 1980
- PRTA 2012
- Country
- TITN United States
- PRTA Ireland
- Employees
- TITN N/A
- PRTA N/A
- Industry
- TITN Other Specialty Stores
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- TITN Consumer Discretionary
- PRTA Health Care
- Exchange
- TITN Nasdaq
- PRTA Nasdaq
- Market Cap
- TITN 341.6M
- PRTA 472.1M
- IPO Year
- TITN 2007
- PRTA N/A
- Fundamental
- Price
- TITN $20.00
- PRTA $8.20
- Analyst Decision
- TITN Buy
- PRTA Buy
- Analyst Count
- TITN 4
- PRTA 10
- Target Price
- TITN $22.25
- PRTA $14.86
- AVG Volume (30 Days)
- TITN 150.1K
- PRTA 1.2M
- Earning Date
- TITN 08-28-2025
- PRTA 08-04-2025
- Dividend Yield
- TITN N/A
- PRTA N/A
- EPS Growth
- TITN N/A
- PRTA N/A
- EPS
- TITN N/A
- PRTA N/A
- Revenue
- TITN $2,580,509,000.00
- PRTA $10,341,000.00
- Revenue This Year
- TITN N/A
- PRTA N/A
- Revenue Next Year
- TITN $0.57
- PRTA $389.77
- P/E Ratio
- TITN N/A
- PRTA N/A
- Revenue Growth
- TITN N/A
- PRTA N/A
- 52 Week Low
- TITN $12.50
- PRTA $4.32
- 52 Week High
- TITN $23.41
- PRTA $22.83
- Technical
- Relative Strength Index (RSI)
- TITN 51.37
- PRTA 58.73
- Support Level
- TITN $18.86
- PRTA $8.05
- Resistance Level
- TITN $21.57
- PRTA $8.73
- Average True Range (ATR)
- TITN 0.77
- PRTA 0.38
- MACD
- TITN 0.06
- PRTA -0.05
- Stochastic Oscillator
- TITN 42.07
- PRTA 47.62
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.